The aim of the current study was to investigate the influence of mouth rinsing carbohydrate at increasing concentrations on ~1 hr cycle time trial performance. Eleven male cyclists completed three experimental trials, following an overnight fast. Cyclists performed a ~1 hr time trial on a cycle ergometer, while rinsing their mouth for 5 s with either a 7% maltodextrin solution (CHO), 14% CHO or a taste-matched placebo (PLA) after every 12.5% of the set amount of work. Heart rate was recorded every 12.5% of the time trial, while RPE and GI comfort were determined every 25% of the time trial. The mouth rinse protocol influenced the time to complete the time trial (p < .001), with cyclists completing the time trial faster during 7% CHO (57.3 ± 4.5 min; p = .004) and 14% CHO (57.4 ± 4.1 min; p = .007), compared with PLA (59.5 ± 4.9 min). There was no difference between the two carbohydrate trials (p = .737). There was a main effect of time (P<0.001) for both heart rate and RPE, but no main effect of trial (p = .107 and p = .849, respectively). Scores for GI comfort ranged from 0–2 during trials, indicating very little GI discomfort during exercise. In conclusion, mouth rinsing and expectorating a 7% maltodextrin solution, for 5 s routinely during exercise was associated with improved cycle time trial performance approximately 1 h in duration. Increasing the carbohydrate concentration of the rinsed solution from 7% to 14% resulted in no further performance improvement.
Ruth M. James, Sarah Ritchie, Ian Rollo, and Lewis J. James
William H. Gurton, Steve H. Faulkner, and Ruth M. James
Purpose: To examine whether an ecologically valid, intermittent, sprint-based warm-up strategy impacted the ergogenic capacity of individualized sodium bicarbonate (NaHCO3) ingestion on 4-km cycling time-trial (TT) performance. Methods: A total of 8 male cyclists attended 6 laboratory visits for familiarization, determination of time to peak blood bicarbonate, and 4 × 4-km cycling TTs. Experimental beverages were administered doubleblind. Treatments were conducted in a block-randomized, crossover order: intermittent warm-up + NaHCO3 (IWSB), intermittent warm-up + placebo, control warm-up + NaHCO3 (CWSB), and control warm-up + placebo (CWP). The intermittent warm-up comprised exercise corresponding to lactate threshold (5 min at 50%, 2 min at 60%, 2 min at 80%, 1 min at 100%, and 2 min at 50%) and 3 × 10-second maximal sprints. The control warm-up comprised 16.5 minutes cycling at 150 W. Participants ingested 0.3 g·kg body mass−1 NaHCO3 or 0.03 g·kg body mass−1 sodium chloride (placebo) in 5 mL·kg body mass−1 fluid (3:2, water and sugar-free orange squash). Paired t tests were conducted for TT performance. Hematological data (blood bicarbonate and blood lactate) and gastrointestinal discomfort were analyzed using repeated-measures analysis of variance. Results: Performance was faster for CWSB versus IWSB (5.0 [6.1] s; P = .052) and CWP (5.8 [6.0] s; P = .03). Pre-TT bicarbonate concentration was elevated for CWSB versus IWSB (+9.3 mmol·L−1; P < .001) and CWP (+7.1 mmol·L−1; P < .001). Post-TT blood lactate concentration was elevated for CWSB versus CWP (+2.52 mmol·L−1; P = .022). Belching was exacerbated pre-warm-up for IWSB versus intermittent warm-up +placebo (P = .046) and CWP (P = .027). Conclusion: An intermittent, sprint-based warm-up mitigated the ergogenic benefits of NaHCO3 ingestion on 4-km cycling TT performance.
Gabriel Perri Esteves, Paul Swinton, Craig Sale, Ruth M. James, Guilherme Giannini Artioli, Hamilton Roschel, Bruno Gualano, Bryan Saunders, and Eimear Dolan
Currently, little is known about the extent of interindividual variability in response to beta-alanine (BA) supplementation, nor what proportion of said variability can be attributed to external factors or to the intervention itself (intervention response). To investigate this, individual participant data on the effect of BA supplementation on a high-intensity cycling capacity test (CCT110%) were meta-analyzed. Changes in time to exhaustion (TTE) and muscle carnosine were the primary and secondary outcomes. Multilevel distributional Bayesian models were used to estimate the mean and SD of BA and placebo group change scores. The relative sizes of group SDs were used to infer whether observed variation in change scores were due to intervention or non-intervention-related effects. Six eligible studies were identified, and individual data were obtained from four of these. Analyses showed a group effect of BA supplementation on TTE (7.7, 95% credible interval [CrI] [1.3, 14.3] s) and muscle carnosine (18.1, 95% CrI [14.5, 21.9] mmol/kg DM). A large intervention response variation was identified for muscle carnosine (σIR = 5.8, 95% CrI [4.2, 7.4] mmol/kg DM) while equivalent change score SDs were shown for TTE in both the placebo (16.1, 95% CrI [13.0, 21.3] s) and BA (15.9, 95% CrI [13.0, 20.0] s) conditions, with the probability that SD was greater in placebo being 0.64. In conclusion, the similarity in observed change score SDs between groups for TTE indicates the source of variation is common to both groups, and therefore unrelated to the supplement itself, likely originating instead from external factors such as nutritional intake, sleep patterns, or training status.